Emerging tropical diseases in Australia. Part 3. Australian bat lyssavirus

Annals of Tropical Medicine and Parasitology

Volumn 104, Issue 8, 2010, Pages 613-621

  Moore, P R ^a,b   Jansen, C C ^a   Graham, G C ^a,c   Smith, I L ^d   Craig, S B ^a,c  

^a QUEENSLAND HEALTH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF THE SUNSHINE COAST   (Australia)

^d CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPLOID CELL VACCINE; POVIDONE IODINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ACTIVE IMMUNIZATION; AUSTRALIA; AUSTRALIAN BAT LYSSAVIRUS; BAT; CLINICAL FEATURE; DISEASE COURSE; HOST; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARALYSIS; PHYLOGENY; PRACTICE GUIDELINE; RABIES; RABIES VIRUS; REVIEW; TROPICAL DISEASE; VIRUS GENOME; VIRUS TRANSMISSION; WOUND CARE;

ANIMALS; AUSTRALIA; BITES AND STINGS; CHIROPTERA; GUIDELINES AS TOPIC; HUMANS; LYSSAVIRUS; PHYLOGENY; POST-EXPOSURE PROPHYLAXIS; RABIES VACCINES; RHABDOVIRIDAE INFECTIONS; RISK FACTORS; WORLD HEALTH ORGANIZATION;

AUSTRALIAN BAT LYSSAVIRUS; LYSSAVIRUS; PTEROPODIDAE; PTEROPUS ALECTO; RABIES VIRUS; SACCOLAIMUS FLAVIVENTRIS;

EID: 78649272568     PISSN: 00034983     EISSN: 13648594     Source Type: Journal    
DOI: 10.1179/136485910X12851868779948     Document Type: Review

References (51)

1. Allworth, A., Murray, K. & Morgan, J. (1996). A human case of encephalitis due to a Lyssavirus recently identified in fruit bats. Communicable Diseases Intelligence, 20, 504.
2. Anon. (1999). Human rabies prevention\United States, 1999. Morbidity and Mortality Weekly Report, 48, 1-21.
3. Badrane, H. & Tordo, N. (2001). Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders. Journal of Virology, 75, 8096-8104.
4. Badrane, H., Bahloul, C, Perrin, P. & Tordo, N. (2001). Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. Journal of Virology, 75, 3268-3276.
5. Baer, G. M., Shaddock, J. H., Houff, S. A., Harrison, A. K. & Gardner, J. J. (1982). Human rabies transmitted by corneal transplant. Archives of Neurology, 39, 103-107.
6. Bourhy, H., Kissi, B. & Tordo, N. (1993). Molecular diversityofthe Lyssavirus genus. Virology, 194, 70-81.
7. Brookes, S. M., Parsons, G, Johnson, N., McElhinney, L. M. & Fooks, A. R. (2005). Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23: 4101-4109.
8. Clark, K. A., Neill, S. U., Smith, J. S., Wilson, P. J., Whadford, V. W. & McKirahan, G. W. (1994). Epizootic canine rabies transmitted by coyotes in south Texas. Journal of the American Veterinary Medical Association, 204, 536-540.
9. Cox, J. H. (1982). The structural proteins of rabies virus. Comparative Immunology, Microbiology and Infectious Diseases, 5, 21-25.
10. De Mattos, C. A., De Mattos, C. C. & Rupprecht, C. E. (1999). Rhabdoviruses. In Fields Virology, 4 Edn, eds Knipe, D. M. & Howley, P. M. pp. 1245-1278. Philadelphia, PA: Lippincott Williams & Wilkins.
11. Dean, D. J., Baer, G. M. & Thompson, W. R. (1963). Studies on the local treatment of rabies-infected wounds. Bulletin of the World Health Organization, 28, 477-486.
12. Delmas, O., Holmes, E. C, Talbi, C, Larrous, F., Dacheux, L., Bouchier, C. & Bourhy, H. (2008). Genomic diversity and evolution of the lyssaviruses. PLoS One, 3, e2057.
13. Dietzschold, B. & Koprowski, H. (2004). Rabies transmission from organ transplants in the USA. Lancet, 364, 648-649.
14. Familusi, J. B., Osunkoya, B. O., Moore, D. L., Kemp, G. E. & Fabiyi, A. (1972). A fatal human infection with Mokola virus. American Journal of Tropical Medicine and Hygiene, 21, 959-963.
15. Field, H. (2005). The ecology of Hendra virus and Australian bat lyssavirus. PhD thesis, School of Veterinary Science, University of Queensland, Brisbane, Australia.
16. Fishbein, D. B., Sawyer, L. A., Reid-Sanden, F. L. & Weir, E. H. (1988). Administration of human diploid-cell rabies vaccine in the gluteal area. New England Journal of Medicine, 318, 124-125.
17. Foord, A. J., Heine, H. G., Pritchard, L. I., Lunt, R. A., Newberry, K. M., Rootes, C. L. & Boyle, D. B. (2006). Molecular diagnosis of lyssaviruses and sequence comparison of Australian bat lyssavirus samples. Australian VeterinaryJournal, 84, 255-230.
18. Fraser, G. C, Hooper, P. T., Lunt, R. A., Gould, A. R., Gleeson, L. J., Hyatt, A. D., Russell, G. M. & Kattenbelt, J. A. (1996). Encephalitis caused by a Lyssavirus in fruit bats in Australia. Emerging Infectious Diseases, 2, 327-331.
19. Hanlon, C. A., Kuzmin, I. V., Blanton, J. D., Weldon, W. C, Manangan, J. S. & Rupprecht, C. E. (2005). Efficacy of rabies biologics against new lyssaviruses from Eurasia. Virus Research, 111, 44-54.
20. Hanna, J. N., Carney, I. K., Smith, G. A., Tannenberg, A. E., Deverill, J. E., Botha, J. A., Serafin, I. L., Harrower, B. J., Fitzpatrick, P. F. & Searle, J. W. (2000). Australian bat lyssavirus infection: a second human case, with a long incubation period. Medical Journal of Australia, 172, 597-599.
21. Hemachudha, T., Phanuphak, P., Sriwanthana, B., Manutsathit, S., Phanthumchinda, K., Siriprasomsup, W., Ukachoke, C, Rasameechan, S. & Kaoroptham, S. (1988). Immunologic study of human encephalitic and paralytic rabies. Preliminary report of 16 patients. American Journal of Medicine, 84, 673-677.
22. Hooper, P. T., Lunt, R. A., Gould, A. R., Samaratunga, H., Hyatt, A. D., Gleeson, L. J., Rodwell, B. J., Rupprecht, C. E., Smith, J. S. & Murray, P. K. (1997). A new lyssavirus\the first endemic rabies-related virus recognized in Australia. Bulletin de l'Institut Pasteur, 95, 209-218.
23. Kaplan, M. M., Cohen, D., Koprowski, H., Dean, D. & Ferrigan, L. (1962). Studies on the local treatment of wounds for the prevention of rabies. Bulletin of the World Health Organization, 26, 765-775.
24. Kassis, R., Larrous, F., Estaquier, J. & Bourhy, H. (2004). Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving cas-pase-8 activation. Journal of Virology, 78, 6543-6555.
25. Kureishi, A., Xu, L. Z., Wu, H. & Stiver, H. G (1992). Rabies in China: recommendations for control. Bulletin of the World Health Organization, 70, 443-450.
26. Kuzmin, I. V., Orciari, L. A., Arai, Y. T., Smith, J. S., Hanlon, C. A., Kameoka, Y. & Rupprecht, C. E. (2003). Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences. VirusResearch, 97, 65-79.
27. Kuzmin, I. V., Huches, G. J., Botvinkin, A. D., Orciari, L. A. & Rupprecht, C. E. (2005). Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantita-tive criteria based on the N gene sequence for lyssavirus genotype definition. Virus Research, 111, 28-43.
28. Lentz, T. L., Burrage, T. G, Smith, A. L., Crick, J. & Tignor, G. H. (1982). Is the acetylcholine receptor a rabies virus receptor? Science, 215, 182-184.
29. McCall, B. J., Field, H. E., Smith, G. A., Storie, G. J. & Harrower, B. J. (2005). Defining the risk of human exposure to Australian bat lyssavirus through poten-tial non-bat animal infection. Communicable Diseases Intelligence, 29, 202-205.
30. McColl, K. A., Chamberlain, T., Lunt, R. A., Newberry, K. M. & Westbury, H. A. (2007). Susceptibility of domestic dogs and cats to Australian bat lyssavirus (ABLV). Veterinary Microbiology, 123, 15-25.
31. Mills, R. P., Swanepoel, R., Hayes, M. M. & Gelfand, M. (1978). Dumb rabies: its development following vaccination in a subject with rabies. Central African Journal of Medicine, 24, 115-117.
32. Muller, T., Cox, J., Peter, W., Schafer, R., Johnson, N., McElhinney, L. M., Geue, J. L., Tjornehoj, K. & Fooks, A. R. (2004). Spill-over of European bat lyssavirus type 1 into a stone marten (Martesfoina) in Germany. Journal of Veterinary Medicine Series B, Infectious Diseases and Veterinary Public Health, 51, 49-54.
33. Nel, L., Jacobs, J., Jaftha, J., von Teichman, B., Bingham, J. & Olivier, M. (2000). New cases of Mokola virus infection in South Africa: a genotypic comparison of southern African virus isolates. Virus Genes, 20, 103-106.
34. Nicholson, K. G. (1996). Cell-culture vaccines for human use: general considerations. In Laboratory Techniques in Rabies, 4th Edn, eds Meslin, F.-X., Kaplan, M. M. & Koprowski, H. pp. 271-279. Geneva: World Health Organization.
35. Pawan, J. L. (1936). Rabies in the vampire bat of Trinidad, with special reference to the clinical course and the latency of infection. Annals of Tropical Medicine and Parasitology, 30, 401-422.
36. Prehaud, C, Lay, S., Dietzschold, B. & Lafon, M. (2003). Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis. Journal of Virology, 77, 10,537-10,547.
37. Rose, J. K. & Whitt, M. A. (1999). Rhabdoviridae: the viruses and their replication. In Fields Virology, 4th Edn, eds Knipe, D. M. & Howley, P. M. pp. 1221-1244. Philadelphia, PA: Lippincott Williams & Wilkins.
38. Rupprecht, C. E., Briggs, D., Brown, C. M., Franka, R., Katz, S. L., Kerr, H. D., Lett, S., Levis, R., Meltzer, M. I., Schaffner, W. & Cieslak, P. R. (2009). Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals. Vaccine, 27, 7141-7148.
39. Samaratunga, H., Searle, J. W. & Hudson, N. (1998). Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat lyssavirus (pteropid lyssavirus) infection. Neuropathology and Applied Neurobiology, 24, 331-335.
40. Shimizu, K., Ito, N., Sugiyama, M. & Minamoto, N. (2006). Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene. Microbiology and Immunology, 50, 975-978.
41. Thoulouze, M. I., Lafage, M., Schachner, M., Hartmann, U., Cremer, H. & Lafon, M. (1998). The neural cell adhesion molecule is a receptor for rabies virus. Journal of Virology, 72, 7181-7190.
42. Thoulouze, M. I., Lafage, M., Yuste, V. J., Baloul, L., Edelman, L., Kroemer, G, Israel, N., Susin, S. A. & Lafon, M. (2003). High level of Bcl-2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces long-term infection. Virology, 314, 549-561.
43. Tjornehoj, K., Fooks, A. R., Agerholm, J. S. & Ronsholt, L. (2006). Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin. Journal of Comparative Pathology, 134, 190-201.
44. Tordo, N., Poch, O., Ermine, A., Keith, G & Rougeon, F. (1988). Completion of the rabies virus genome sequence determination: highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses. Virology, 165, 565-576.
45. Tsiang, H., Ceccaldi, P. E. & Lycke, E. (1991). Rabies virus infection and transport in human sensory dorsal root ganglia neurons. Journal of General Virology, 72, 1191-1194.
46. Tuffereau, C, Benejean, J., Blondel, D., Kieffer, B. & Flamand, A. (1998). Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO Journal, 17, 7250-7259.
47. Warrell, D. A. (1976). The clinical picture of rabies in man. Transactions of the Royal Society of Tropical Medicine and Hygiene, 70, 188-195.
48. Warrilow, D., Smith, I. L., Harrower, B. & Smith, G A. (2002). Sequence analysis of an isolate from a fatal human infection of Australian bat lyssavirus. Virology, 297, 109-119.
49. Warrilow, D., Harrower, B., Smith, I. L., Field, H., Taylor, R., Walker, C. & Smith, G A. (2003). Public health surveillance for Australian bat lyssavirus in Queensland, Australia, 2000-2001. Emerging Infectious Diseases, 9, 262-264.
50. World Health Organization (2002). Current WHO Guidelines for Rabies Pre-and Post-exposure Treatment in Humans. Geneva: WHO.
51. World Health Organization (2008). Rabies. Fact Sheet No. 99. Geneva: WHO.